Viewing Study NCT03169361


Ignite Creation Date: 2025-12-24 @ 12:09 PM
Ignite Modification Date: 2025-12-27 @ 10:18 PM
Study NCT ID: NCT03169361
Status: COMPLETED
Last Update Posted: 2023-12-07
First Post: 2017-05-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) "Relapsed/Refractory Multiple Myeloma"
Sponsor: Takeda
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-05-24
Start Date Type: ACTUAL
Primary Completion Date: 2022-03-08
Primary Completion Date Type: ACTUAL
Completion Date: 2022-03-08
Completion Date Type: ACTUAL
First Submit Date: 2017-05-24
First Submit QC Date: None
Study First Post Date: 2017-05-30
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-03-05
Results First Submit QC Date: None
Results First Post Date: 2023-12-07
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-03-05
Last Update Post Date: 2023-12-07
Last Update Post Date Type: ACTUAL